BIOCRATES
Desconocido
INITIATE: INnate ImmunomeTabolIsm as Antiviral TargEt
BIOCRATES LIFE SCIENCES AG
participó en un
H2020:
H2020-MSCA-ITN-2018
Viral outbreaks and epidemics continue to impose high morbidity and mortality burdens in mankind and animals, emphasizing the urgent need fo...
2019-05-21 - 2023-04-30 | Financiado
2019-05-21 - 2023-04-30 | Financiado
REPO-TRIAL: An in silico based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a m...
BIOCRATES LIFE SCIENCES AG
participó en un
H2020:
H2020-SC1-2016-2017
Our programme will develop an innovative in-silico based approach to improve the efficacy and precision of drug repurposing trials. We have...
2017-10-31 - 2024-01-31 | Financiado
2017-10-31 - 2024-01-31 | Financiado
TRANSMIT: TRANSlating the role of Mitochondria in Tumorigenesis
BIOCRATES LIFE SCIENCES AG
participó en un
H2020:
H2020-MSCA-ITN-2016
The consolidation of the knowledge that cancer is not only a genetic, but also a metabolic disease, has led scientists to investigate the in...
2016-08-16 - 2021-06-30 | Financiado
2016-08-16 - 2021-06-30 | Financiado
NUTRITECH: Application of new technologies and methods in nutrition research the example of phenotypic flexib...
BIOCRATES LIFE SCIENCES AG
participó en un
FP7:
NutriTech will build on the foundations of traditional human nutrition research using cutting-edge analytical technologies and methods to co...
Financiado
Financiado
SYSVASC: Systems Biology to Identify Molecular Targets for Vascular Disease Treatment
BIOCRATES LIFE SCIENCES AG
participó en un
FP7:
Asymptomatic vascular damage accumulates for years before patients are identified and subjected to therapeutic measures. The limited knowled...
Financiado
Financiado
BIOMARCARE: Biomarker for Cardiovascular Risk Assessment in Europe
BIOCRATES LIFE SCIENCES AG
participó en un
FP7:
Biomarkers are considered as tools to enhance cardiovascular risk estimation. However, the value of biomarkers on risk estimation beyond Eur...
Financiado
Financiado
NATPROTEC: Integrated technologies for the discovery and development of cosmeceutical agents from plant biodive...
BIOCRATES LIFE SCIENCES AG
participó en un
FP7:
NATPROTEC aims to discover and carry to the stage of development innovative products in the area of cosmeceuticals originating from European...
Financiado
Financiado
BRAINAGE: Impact of Prenatal Stress on BRAIN AGEing
BIOCRATES LIFE SCIENCES AG
participó en un
FP7:
Healthy brain ageing is a major determinant of quality life-long health, allowing integration into society at all ages. Human epidemiologica...
Financiado
Financiado
SYSKID: Systems biology towards novel chronic kidney disease diagnosis and treatment
BIOCRATES LIFE SCIENCES AG
participó en un
FP7:
Chronic kidney disease (CKD) affects up to 10% of the population. Besides eventual progression towards end stage renal disease CKD impacts t...
Financiado
Financiado
METAFLUX: Metabolic Flux Analysis and Cancer
BIOCRATES LIFE SCIENCES AG
participó en un
FP7:
The post-genomic era has been driven by the development of technologies that allow the function of cells and whole organisms to be explored...
Financiado
Financiado
* No se disponen de datos de la empresa actual.